Jaia Robotics is a provider and developer of microsized autonomous and subsurface marine vehicles. It also provides comprehensive data collection services helping clients to affordable aquatic data collection. It also provides a multi-sensor configurable technology that requires minimal user training with wide-ranging capabilities compared to traditional crewed or uncrewed data collection systems.
Theromics Inc. develops cell therapies. It offers HeatSYNC Gel, a thermal accelerant (TA) that augments MW and RF energy by increasing local tissue electrical conductivity in a reproducible and effective manner. The company’s TA absorbs microwave energy effectively preventing heat loss caused by blood flow in large vessels adjacent to ablation zone; optimizes the shape of the ablation zone into a circle making the ablation volume predictable; and produces a larger ablation area making it easier to target the tumor center and with 3-D modeling optimizes antenna guidance into tumor mass. Theromics Inc. was founded in 2016 and is based in West Bridgewater, Massachusetts.
AOA, based in Boston, New York, and London, is a female-led company focused on developing innovative cancer diagnostics specifically for women's health. The company is dedicated to creating the first accurate early-stage liquid biopsy test for ovarian cancer, which aims to enhance clinical practices, reduce patient mortality, and offer cost savings for healthcare payers. Utilizing an artificial intelligence-enabled platform, AOA's technology analyzes tumor marker gangliosides to facilitate the early detection of ovarian cancer. This approach not only helps healthcare providers implement more effective treatment strategies but also ensures that patients can access life-saving treatments sooner and at a more affordable cost.
Lenoss Medical engages in providing solutions that support the natural osseous healing process.
First Light Biosciences develops breakthrough automated medical diagnostic products for rapid, sensitive, and cost-effective detection of Healthcare-Associated Infections (HAI). The products address the need for cost-effective and accurate diagnostics to meet the explosive growth in testing. New testing is being driven by clinical studies showing that testing for infectious agents can help to dramatically lower the rate of hospital infections. Based on its proprietary MultiPath detection technology, First Light’s products combine the performance of the most advanced commercial laboratory tests with unprecedented affordability and ease-of-use.
Spiro Technologies, Inc. develops a relationship management platform that works in the background and recommends sales teams on different actions. The company’s platform creates contacts; eliminates data entry; provides sales suggestions; delivers reports; assists in making, receiving, and transcribing calls and texts from Spiro Voice number; and assists sales teams to track and manage opportunities. It serves construction, finance, manufacturing, professional service, and technology industries. The company was incorporated in 2014 and is based in Boston, Massachusetts.
RevBio is commercializing an injectable, self-setting bone adhesive that can bond bone to bone and bone to metal to stabilize implant devices. Over time, the adhesive biodegrades and is replaced by new bone. This unique material will reduce the duration and complexity of medical procedures, allow for more minimally invasive surgeries, and will improve patient outcomes by reducing recovery time and the overall cost of care.
At Orange Photonics, they are building products and services that drive toward a reliable, efficient and professional commerce infrastructure for the marijuana industry.
Their initial product, LightLab, will set the bar for accurate, repeatable, cost-effective on-site marijuana potency testing. The services we will build around LightLab will collect and deliver data to aid decision makers in this market. Their customers want to make better data-based decisions in order to grow and optimize their business.
Pykus Therapeutics, Inc. was founded in 2016 to develop a dissolvable intraocular surgical device to make retinal surgery less painful and more successful.
The co-founders were ophthalmology residents at the Massachusetts Eye and Ear Infirmary and Harvard Medical School when they developed a novel hydrogel to replace the use of intraocular gas during retinal surgery. This innovation will eliminate the extreme burden placed on patients including the requirement for face-down positioning, inability to see for weeks, and inability to fly for weeks.
XCube R&D provides software infrastructure that automates testing and training process for machine learning algorithms. The company specializes in providing automation for OEMs and auto suppliers developing advanced driver assistance systems (ADAS) and autonomous vehicle programs. It offers StreamX Platform, a web-based interface to capture and store multi-sensor data, tag or annotate data based on the content important to the application, search data during the tagging and mining phase, launch an application, and save and automate a process. The company offers solutions in the areas of test and validation, training classifiers, real-time analysis, and automated regression testing. XCube R&D was founded in 2006 and is based in Nashua, New Hampshire.
Building Conversation offers a unique and innovative augmented reality solution to help real estate developers and architecture firms communicate their ideas more clearly with each other and the general public. Their mobile app offers a variety of highly customizable capabilities directed at streamlining and improving the building proposal process specific to your unique challenges. Small neighborhood store, high end residential or billion-dollar waterfront development and everything in between, arc will make the outcome faster and easier and the process saving you time and money.
Datarista is reinventing how third-party sales & marketing data providers deliver data to their customers. The Datarista platform provides real time, relevant third party data delivery, integration and update services for both enhancement and prospecting inside of the most popular CRM and Marketing Automation platforms. Datarista is a service extension for the data providers to enable their sales teams to sell an end-to-end solution.
Datarista is PaaS for your DaaS!
Xeno Biosciences Inc. is a biotechnology company based in Somerville, Massachusetts, focused on developing innovative treatments for obesity and related metabolic diseases. Founded in 2015, the company is pioneering a novel class of therapeutics designed to mimic the effects of gastric bypass surgery. Its lead product, XEN-101, is an oral formulation that delivers molecular oxygen to the lower gut, facilitating a shift in the gut microbiome toward a state associated with weight loss, similar to the outcomes of Roux-en-Y Gastric Bypass surgery. Through this approach, Xeno Biosciences aims to address significant unmet needs in the management of metabolic disorders.
Embedded sensors analyze data from concrete as it is curing to report the strength of the concrete in real time. Using known methods from ASTM and their library of concrete mixes, all you need is their sensor and a smartphone.
With real-time feedback about the curing status of concrete, you will know:
- Concrete cured under acceptable conditions
- Concrete is not too cold
- Concrete is not too hot
- When to take the forms down
- When to move on with work
Siamab Therapeutics is a biopharmaceutical company that develops therapies targeting abnormal carbohydrates found only on cancer cells. It has developed a platform of technologies that enables the discovery and development of anti-TACA therapeutic antibodies.
The company’s core technologies were licensed from the laboratory of Ajit Varki, a professional in glycobiology and sialic-acid biochemistry. It has brought together a team of scientists and advisors in oncology, glycoimmunology, and antibody engineering to support its anti-TACA antibody discovery and development programs.
Siamab Therapeutics was founded in 2006 and is headquartered in Newton, M.A.
Avaxia Biologics, Inc. operates as a biopharmaceutical company that develops oral antibody therapeutics. It offers gastrointestinal diseases, such as inflammatory bowel diseases, celiac disease, necrotizing enterocolitis, radiation syndrome, oral mucositis, and diabetes and obesity. Avaxia Biologics, Inc. has a strategic collaboration with Courtagen Life Sciences, Inc. The company was founded in 2005 and is based in Lexington, Massachusetts. Avaxia Biologics, Inc. operates as a subsidiary of Circle33 LLC.
Mofuse offers a web based platform to build and manage mobile web sites. They provide a monthly subscription service to help businesses deliver mobile media. MoFuse Premium gives publishers a platform to publish, promote, monetize and analyze their mobile properties.
iQuartic, Inc. specializes in developing cloud platforms aimed at data networking and mining within the healthcare sector. The company's technology facilitates essential functions such as EHR and claims auditing, quality benchmarking, population health management, disease management, risk profiling, and revenue optimization. Key offerings include the iQ EHR Network, which integrates disparate EMR systems across various facilities; iQ EHR Auditing, which utilizes advanced analytics to identify inconsistencies in EHR data; and iQ ACO Software, designed for accountable care organizations to analyze networks and patient data comprehensively. Additional products encompass predictive modeling tools like the EHR Data Auditor, which focuses on HIV patient reporting; the Diabetes Management Scorecard; and the COPD Population Profiler, among others. These tools aim to enhance chronic disease management, predict hospital readmissions, and improve clinician profiling. Founded in 2012, iQuartic is headquartered in Boston, Massachusetts.
Avaxia Biologics, Inc. operates as a biopharmaceutical company that develops oral antibody therapeutics. It offers gastrointestinal diseases, such as inflammatory bowel diseases, celiac disease, necrotizing enterocolitis, radiation syndrome, oral mucositis, and diabetes and obesity. Avaxia Biologics, Inc. has a strategic collaboration with Courtagen Life Sciences, Inc. The company was founded in 2005 and is based in Lexington, Massachusetts. Avaxia Biologics, Inc. operates as a subsidiary of Circle33 LLC.
Pixability is a video advertising software company that specializes in optimizing complex campaigns across YouTube and Connected TV using data science. It offers a cloud-based platform that includes various features such as campaign management, channel management, and insights into industry trends and competitive environments. The company’s flagship product, PixabilityONE, is designed to enhance video advertising efforts by streamlining campaign creation, benchmarking, testing, and reporting. Additionally, Pixability provides BrandTrack, a solution that helps marketers measure brand performance on YouTube and adjust their strategies accordingly. Founded in 2008 and headquartered in Boston, Massachusetts, Pixability has expanded its presence with offices in New York, San Francisco, Chicago, and London, serving a diverse clientele that includes media agencies, brands, and in-house marketing teams.
Copiun has set out to provide a PC backup and User Data Management solution that is less rather than more less for end users to do, less for IT administrators to do, and less expensive. This minimalistic approach has lead to a solution that while ideal for mid to large enterprises, is automated, secure, transparent to end users, and requires nearly zero IT administration, all at a cost that is nearly half the total cost of ownership when compared to traditional PC backup solutions.
SmartCells, Inc. designs and develops insulin products. It offers SmartInsulin, a self regulating injectable formulation for treating diabetes. The company's polymer-based dosing technology is used for various applications, such as fertility, thyroid, and growth hormone deficiencies; treatments with poor compliance or therapeutic window issues, such as oncology; and drug-device combinations. SmartCells, Inc. was founded in 2003 and is based in Beverly, Massachusetts.
Crimson Hexagon, Inc. is a provider of social media analysis software that enables businesses and organizations worldwide to gain insights from social data. Founded in 2007 and headquartered in Boston, Massachusetts, the company offers a platform that allows brands and agencies to address critical business questions, enhance media planning, and evaluate return on investment. The platform utilizes artificial intelligence to analyze vast amounts of unstructured text and images from various data sources, helping clients understand consumer behavior, monitor brand perception, and identify market trends. Crimson Hexagon serves a diverse range of clients, including major corporations like Anheuser-Busch InBev, Adidas, and Starbucks. Additionally, the company supports nonprofit and educational sectors by providing reduced-fee access to its analytics tools. As of late 2018, Crimson Hexagon operates as a subsidiary of Runtime Collective Limited.
Tikatok is an on line community designed for children to write, illustrate and publish their own stories into real books. Tikatok was started by two moms that felt it is essential to give young children a place to channel their creativity and publish their work. For less than $20, children can self-publish their own paperback or hardcover book. With the help of "story sparks," a template-based system, children can easily start writing and illustrating stories. They can upload art directly to the site or mail it in. There are packages to schools and libraries for group orders. The site is very family centered, and has an awesome and well-thought-out privacy policy.
SmartCells, Inc. designs and develops insulin products. It offers SmartInsulin, a self regulating injectable formulation for treating diabetes. The company's polymer-based dosing technology is used for various applications, such as fertility, thyroid, and growth hormone deficiencies; treatments with poor compliance or therapeutic window issues, such as oncology; and drug-device combinations. SmartCells, Inc. was founded in 2003 and is based in Beverly, Massachusetts.
GateRocket, Inc. provides verification and debugging solutions for FPGAs. It offers RocketDrive, a device native verification system for complex FPGAs, which accelerates verification throughput and identifies problems with IP blocks, pin-outs, and tool chain anomalies. The company also provides RocketVision, a FPGA debug solution that automates test point insertion and detects differences between RTL and FPGA devices. The company was incorporated in 2003 and is headquartered in Bedford, Massachusetts.